Medtronic Gross Profit 2010-2025 | MDT

Medtronic annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Medtronic gross profit for the quarter ending April 30, 2025 was $5.781B, a 4.27% increase year-over-year.
  • Medtronic gross profit for the twelve months ending April 30, 2025 was $21.905B, a 3.58% increase year-over-year.
  • Medtronic annual gross profit for 2025 was $21.905B, a 3.58% increase from 2024.
  • Medtronic annual gross profit for 2024 was $21.148B, a 3.12% increase from 2023.
  • Medtronic annual gross profit for 2023 was $20.508B, a 4.8% decline from 2022.
Medtronic Annual Gross Profit
(Millions of US $)
2025 $21,905
2024 $21,148
2023 $20,508
2022 $21,541
2021 $19,634
2020 $19,489
2019 $21,402
2018 $20,886
2017 $20,416
2016 $19,691
2015 $13,952
2014 $12,672
2013 $12,464
2012 $12,295
2011 $11,808
2010 $11,810
2009 $11,081
Medtronic Quarterly Gross Profit
(Millions of US $)
2025-04-30 $5,781
2025-01-31 $5,513
2024-10-31 $5,457
2024-07-31 $5,154
2024-04-30 $5,544
2024-01-31 $5,307
2023-10-31 $5,223
2023-07-31 $5,074
2023-04-30 $5,565
2023-01-31 $5,038
2022-10-31 $5,050
2022-07-31 $4,855
2022-04-30 $5,498
2022-01-31 $5,304
2021-10-31 $5,350
2021-07-31 $5,389
2021-04-30 $5,536
2021-01-31 $5,154
2020-10-31 $4,942
2020-07-31 $4,002
2020-04-30 $3,733
2020-01-31 $5,317
2019-10-31 $5,312
2019-07-31 $5,127
2019-04-30 $5,663
2019-01-31 $5,281
2018-10-31 $5,278
2018-07-31 $5,180
2018-04-30 $5,746
2018-01-31 $5,175
2017-10-31 $4,927
2017-07-31 $5,038
2017-04-30 $5,477
2017-01-31 $5,015
2016-10-31 $5,019
2016-07-31 $4,905
2016-04-30 $5,204
2016-01-31 $4,793
2015-10-31 $4,876
2015-07-31 $4,818
2015-04-30 $4,370
2015-01-31 $3,190
2014-10-31 $3,224
2014-07-31 $3,168
2014-04-30 $3,394
2014-01-31 $3,113
2013-10-31 $3,104
2013-07-31 $3,061
2013-04-30 $3,326
2013-01-31 $3,028
2012-10-31 $3,075
2012-07-31 $3,035
2012-04-30 $3,250
2012-01-31 $2,987
2011-10-31 $3,063
2011-07-31 $2,995
2011-04-30 $3,063
2011-01-31 $2,923
2010-10-31 $2,942
2010-07-31 $2,880
2010-04-30 $2,988
2010-01-31 $2,939
2009-10-31 $2,916
2009-07-31 $2,967
2009-04-30 $2,897
2009-01-31 $2,646
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $114.826B $33.537B
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $209.668B 24.59
Boston Scientific (BSX) United States $154.824B 38.76
Stryker (SYK) United States $148.439B 31.04
EssilorLuxottica (ESLOY) France $131.494B 0.00
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Haleon (HLN) United Kingdom $43.081B 24.59
ResMed (RMD) United States $37.598B 28.24
GE HealthCare Technologies (GEHC) United States $34.909B 16.57
Agilent Technologies (A) United States $33.054B 21.55
Terumo (TRUMY) Japan $24.345B 31.62
Koninklijke Philips (PHG) Netherlands $23.697B 16.63
Insulet (PODD) United States $19.948B 78.30
Zimmer Biomet Holdings (ZBH) United States $18.776B 12.06
Baxter (BAX) United States $14.312B 10.69
Smith & Nephew SNATS (SNN) United Kingdom $13.087B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.794B 23.64
Lantheus Holdings (LNTH) United States $5.092B 12.85
Perrigo (PRGO) Ireland $3.733B 9.46
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.529B 16.07
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.347B 27.82
ICU Medical (ICUI) United States $3.070B 22.64
LeMaitre Vascular (LMAT) United States $1.855B 41.47
QuidelOrtho (QDEL) United States $1.804B 12.41
AtriCure (ATRC) United States $1.473B 0.00
Acuren (TIC) United States $1.444B 0.00
AdaptHealth (AHCO) United States $1.242B 12.60
Green Thumb Industries (GTBIF) United States $1.207B 27.14
Phibro Animal Health (PAHC) United States $1.205B 15.40
Neogen (NEOG) United States $1.055B 13.50
BioLife Solutions (BLFS) United States $1.025B 0.00
InMode (INMD) Israel $0.891B 8.98
Kestra Medical Technologies (KMTS) United States $0.845B 0.00
Curaleaf Holdings (CURLF) Canada $0.674B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Owens & Minor (OMI) United States $0.617B 5.12
Tilray Brands (TLRY) Canada $0.615B 0.00
Evolus (EOLS) United States $0.602B 0.00
CeriBell (CBLL) United States $0.565B 0.00
Valneva SE (VALN) France $0.553B 0.00
Surmodics (SRDX) United States $0.438B 0.00
SNDL (SNDL) Canada $0.410B 0.00
Capricor Therapeutics (CAPR) United States $0.327B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Sanuwave Health (SNWV) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Cresco Labs (CRLBF) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.256B 75.83
OraSure Technologies (OSUR) United States $0.245B 0.00
Sanara MedTech (SMTI) United States $0.244B 0.00
ZimVie (ZIMV) United States $0.241B 10.96
Biote (BTMD) United States $0.228B 6.42
Brainsway (BWAY) Israel $0.219B 58.05
Verano Holdings (VRNOF) United States $0.204B 0.00
Canopy Growth (CGC) Canada $0.204B 0.00
Omeros (OMER) United States $0.204B 0.00
High Tide (HITI) Canada $0.203B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Exagen (XGN) United States $0.153B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.125B 15.33
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.74
MacroGenics (MGNX) United States $0.097B 0.00
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.052B 0.00
United-Guardian (UG) United States $0.042B 14.54
Nephros (NEPH) United States $0.038B 51.14
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00